DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Pfreundschuh M. et al
German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL), Medizinische Klinik I, Saarland University Medical School, Homburg, Saarland, Germany. Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
Blood 2005; 106 (11) abstract 13
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.